March 2019, the portion of shareholders’ equity amounted to Baht 481 million, an increase of Baht 31 million, or 6.77% from those of previous year- end, derived from profit for the period of Q1/2019

accounts payable. Shareholders’ Equity: As of 30 June 2019, the portion of shareholders’ equity amounted to Baht 462 million, an increase of Baht 12 million, or 2.56% from those of previous year- end

, and trade accounts payable. Shareholders’ Equity: As of 30 June 2018, the portion of shareholders’ equity amounted to Baht 445 million, same amount as those of previous year-end, derived from profit for

(excluding FX rate effect and a gain on equity interest in an associate) rose significantly by 28.6% from the previous quarter as a result of higher sales and better economies of scale at the new plant. This

Liabilities 914 784 925 Total Liabilities 930 797 935 Shareholder’s Equity 431 445 431 OPERATING RESULT (MILLION BAHT) Sales Revenue 3,979 3,727 2,811 Gross Profit 258 247 206 Operating Profit 131 126 97 Profit

reviewed by certified public auditor as follows: Overall performance results of the Company for the three-month period ended 30 September 2018, compared to the same period of the previous year were as

by both OPD (6% growth) and IPD (5% growth). This growth was not as robust as previous year’s growth because the drought prolonged until mid of this 3rd quarter. Number of patients of 3Q19 slightly

comprehensive loss for the period (63.67) (61.60) (2.07) 3.36 Non-controlling interests (4.30) (3.39) (0.91) 26.68 Equity holders of the Company (59.26) (57.72) (1.54) 2.67 Basic loss per share (0.08) (0.08

698 Total Liabilities 797 817 707 Shareholder’s Equity 445 451 478 OPERATING RESULT (MILLION BAHT) Sales Revenue 3,727 3,660 3,610 Gross Profit 247 263 274 Operating Profit 126 124 154 Profit for the

’ Equity: As of 31 March 2020, the portion of shareholders’ equity amounted to Baht 513 million, an increase of Baht 35 million, or 7.29% from those of previous year- end, derived from profit for the period